Application 217003
- Type
- NDA
- Sponsor
- PHARMACYCLICS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IMBRUVICA | IBRUTINIB | SUSPENSION;ORAL | 70MG/ML | No | No |
| 002 | IMBRUVICA | IBRUTINIB | CAPSULE;ORAL | 70MG | No | No |
| 003 | IMBRUVICA | IBRUTINIB | CAPSULE;ORAL | 140MG | No | No |
| 004 | IMBRUVICA | IBRUTINIB | TABLET;ORAL | 140MG | No | No |
| 005 | IMBRUVICA | IBRUTINIB | TABLET;ORAL | 230MG | No | No |
| 006 | IMBRUVICA | IBRUTINIB | TABLET;ORAL | 420MG | No | No |
| 007 | IMBRUVICA | IBRUTINIB | TABLET;ORAL | 560MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N217003-001 | IMBRUVICA | IBRUTINIB | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N217003-001 | 7514444 | 2026-12-28 | Drug substance, Drug product | 2022-09-21 | |
| N217003-001 | 8476284 | 2026-12-28 | U-3843 | 2024-03-19 | |
| N217003-001 | 8476284 | 2026-12-28 | U-3844 | 2024-03-19 | |
| N217003-001 | 8476284 | 2026-12-28 | U-3845 | 2024-03-19 | |
| N217003-001 | 8497277 | 2026-12-28 | U-2666 | 2022-09-21 | |
| N217003-001 | 8497277 | 2026-12-28 | U-2970 | 2022-09-21 | |
| N217003-001 | 8497277 | 2026-12-28 | U-3422 | 2022-09-21 | |
| N217003-001 | 8497277 | 2026-12-28 | U-3842 | 2022-09-21 | |
| N217003-001 | 8497277 | 2026-12-28 | U-3843 | 2022-09-21 | |
| N217003-001 | 8497277 | 2026-12-28 | U-3844 | 2022-09-21 | |
| N217003-001 | 8497277 | 2026-12-28 | U-3845 | 2022-09-21 | |
| N217003-001 | 8697711 | 2026-12-28 | Drug substance, Drug product | 2022-09-21 | |
| N217003-001 | 8703780 | 2026-12-28 | U-2666 | 2024-03-19 | |
| N217003-001 | 8703780 | 2026-12-28 | U-3842 | 2024-03-19 | |
| N217003-001 | 8735403 | 2026-12-28 | Drug substance, Drug product | 2022-09-21 | |
| N217003-001 | 8754091 | 2026-12-28 | Drug product | 2022-09-21 | |
| N217003-001 | 8952015 | 2026-12-28 | U-2666 | 2024-03-19 | |
| N217003-001 | 8952015 | 2026-12-28 | U-3842 | 2024-03-19 | |
| N217003-001 | 8952015 | 2026-12-28 | U-3843 | 2024-03-19 | |
| N217003-001 | 8952015 | 2026-12-28 | U-3844 | 2024-03-19 | |
| N217003-001 | 8952015 | 2026-12-28 | U-3845 | 2024-03-19 | |
| N217003-001 | 8957079 | 2026-12-28 | Drug substance, Drug product | 2022-09-21 | |
| N217003-001 | 9181257 | 2026-12-28 | Drug substance | 2022-09-21 | |
| N217003-001 | 8563563 | 2027-04-26 | U-2666 | 2024-03-19 | |
| N217003-001 | 8563563 | 2027-04-26 | U-3842 | 2024-03-19 | |
| N217003-001 | 8563563 | 2027-04-26 | U-3843 | 2024-03-19 | |
| N217003-001 | 8563563 | 2027-04-26 | U-3844 | 2024-03-19 | |
| N217003-001 | 8563563 | 2027-04-26 | U-3845 | 2024-03-19 | |
| N217003-001 | 7514444*PED | 2027-06-28 | Pediatric extension | ||
| N217003-001 | 8497277*PED | 2027-06-28 | Pediatric extension | ||
| N217003-001 | 8697711*PED | 2027-06-28 | Pediatric extension | ||
| N217003-001 | 8735403*PED | 2027-06-28 | Pediatric extension | ||
| N217003-001 | 8754091*PED | 2027-06-28 | Pediatric extension | ||
| N217003-001 | 8957079*PED | 2027-06-28 | Pediatric extension | ||
| N217003-001 | 9181257*PED | 2027-06-28 | Pediatric extension | ||
| N217003-001 | 8008309 | 2027-11-13 | Drug substance, Drug product | 2022-09-21 | |
| N217003-001 | 8008309*PED | 2028-05-13 | Pediatric extension | ||
| N217003-001 | 10004746 | 2031-06-03 | U-3846 | 2024-03-19 | |
| N217003-001 | 10004746 | 2031-06-03 | U-3847 | 2024-03-19 | |
| N217003-001 | 10004746 | 2031-06-03 | U-3848 | 2024-03-19 | |
| N217003-001 | 10004746 | 2031-06-03 | U-3849 | 2024-03-19 | |
| N217003-001 | 10016435 | 2031-06-03 | U-3845 | 2024-03-19 | |
| N217003-001 | 10478439 | 2031-06-03 | U-2666 | 2022-09-21 | |
| N217003-001 | 10478439 | 2031-06-03 | U-2970 | 2022-09-21 | |
| N217003-001 | 10478439 | 2031-06-03 | U-3422 | 2022-09-21 | |
| N217003-001 | 10478439 | 2031-06-03 | U-3842 | 2022-09-21 | |
| N217003-001 | 10478439 | 2031-06-03 | U-3843 | 2022-09-21 | |
| N217003-001 | 10478439 | 2031-06-03 | U-3844 | 2022-09-21 | |
| N217003-001 | 10478439 | 2031-06-03 | U-3845 | 2022-09-21 | |
| N217003-001 | 10751342 | 2031-06-03 | U-2666 | 2024-03-19 | |
| N217003-001 | 10751342 | 2031-06-03 | U-3842 | 2024-03-19 | |
| N217003-001 | 10751342 | 2031-06-03 | U-3843 | 2024-03-19 | |
| N217003-001 | 10751342 | 2031-06-03 | U-3844 | 2024-03-19 | |
| N217003-001 | 11672803 | 2031-06-03 | U-2666 | 2024-03-19 | |
| N217003-001 | 11672803 | 2031-06-03 | U-3842 | 2024-03-19 | |
| N217003-001 | 11672803 | 2031-06-03 | U-3843 | 2024-03-19 | |
| N217003-001 | 11672803 | 2031-06-03 | U-3844 | 2024-03-19 | |
| N217003-001 | 8999999 | 2031-06-03 | U-2666 | 2024-03-19 | |
| N217003-001 | 8999999 | 2031-06-03 | U-3842 | 2024-03-19 | |
| N217003-001 | 8999999 | 2031-06-03 | U-3843 | 2024-03-19 | |
| N217003-001 | 8999999 | 2031-06-03 | U-3844 | 2024-03-19 | |
| N217003-001 | 9125889 | 2031-06-03 | U-3845 | 2024-03-19 | |
| N217003-001 | 9801881 | 2031-06-03 | U-3846 | 2024-03-19 | |
| N217003-001 | 9801881 | 2031-06-03 | U-3847 | 2024-03-19 | |
| N217003-001 | 9801883 | 2031-06-03 | U-2666 | 2024-03-19 | |
| N217003-001 | 9801883 | 2031-06-03 | U-3842 | 2024-03-19 | |
| N217003-001 | 9801883 | 2031-06-03 | U-3843 | 2024-03-19 | |
| N217003-001 | 9801883 | 2031-06-03 | U-3844 | 2024-03-19 | |
| N217003-001 | 10478439*PED | 2031-12-03 | Pediatric extension | ||
| N217003-001 | 10106548 | 2033-06-03 | Drug substance, Drug product | 2022-09-21 | |
| N217003-001 | 10125140 | 2033-06-03 | Drug substance, Drug product | 2022-09-21 | |
| N217003-001 | 10961251 | 2033-06-03 | Drug product | 2022-09-21 | |
| N217003-001 | 9725455 | 2033-06-03 | Drug substance | 2022-09-21 | |
| N217003-001 | 9296753 | 2033-10-30 | Drug substance | 2022-09-21 | |
| N217003-001 | 10106548*PED | 2033-12-03 | Pediatric extension | ||
| N217003-001 | 10125140*PED | 2033-12-03 | Pediatric extension | ||
| N217003-001 | 10961251*PED | 2033-12-03 | Pediatric extension | ||
| N217003-001 | 9725455*PED | 2033-12-03 | Pediatric extension | ||
| N217003-001 | 9296753*PED | 2034-04-30 | Pediatric extension | ||
| N217003-001 | 10463668 | 2034-10-24 | U-2970 | 2024-03-19 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N217003-001 | NP | 2025-08-24 |
| N217003-001 | PED | 2026-02-24 |
| N217003-001 | ODE-405 | 2029-08-24 |
| N217003-001 | PED | 2030-02-24 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 8072bd15b7f6… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | e64feba35796… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N217003-001 | IMBRUVICA | 70MG/ML | SUSPENSION / ORAL | RLD, RS | 2022-08-24 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 9181257 | 2026-12-28 | Drug substance | 2022-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8563563 | 2027-04-26 | U-3844 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8563563 | 2027-04-26 | U-3843 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8563563 | 2027-04-26 | U-3842 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8563563 | 2027-04-26 | U-2666 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8563563 | 2027-04-26 | U-3845 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 7514444*PED | 2027-06-28 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8497277*PED | 2027-06-28 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8697711*PED | 2027-06-28 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8735403*PED | 2027-06-28 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8754091*PED | 2027-06-28 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8957079*PED | 2027-06-28 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 9181257*PED | 2027-06-28 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8008309 | 2027-11-13 | Drug substance, Drug product | 2022-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8008309*PED | 2028-05-13 | Pediatric extension | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10004746 | 2031-06-03 | U-3846 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10004746 | 2031-06-03 | U-3848 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10004746 | 2031-06-03 | U-3849 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10004746 | 2031-06-03 | U-3847 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10016435 | 2031-06-03 | U-3845 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10478439 | 2031-06-03 | U-3422 | 2022-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10478439 | 2031-06-03 | U-3842 | 2022-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10478439 | 2031-06-03 | U-3844 | 2022-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10478439 | 2031-06-03 | U-2666 | 2022-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10478439 | 2031-06-03 | U-2970 | 2022-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10478439 | 2031-06-03 | U-3843 | 2022-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10478439 | 2031-06-03 | U-3845 | 2022-09-21 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10751342 | 2031-06-03 | U-2666 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10751342 | 2031-06-03 | U-3844 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10751342 | 2031-06-03 | U-3843 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 10751342 | 2031-06-03 | U-3842 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 11672803 | 2031-06-03 | U-2666 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 11672803 | 2031-06-03 | U-3842 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 11672803 | 2031-06-03 | U-3844 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 11672803 | 2031-06-03 | U-3843 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8999999 | 2031-06-03 | U-2666 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8999999 | 2031-06-03 | U-3842 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8999999 | 2031-06-03 | U-3843 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 8999999 | 2031-06-03 | U-3844 | 2024-03-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | 9125889 | 2031-06-03 | U-3845 | 2024-03-19 | caaa826d4ba7… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N217003-001 | NP | 2025-08-24 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N217003-001 | PED | 2026-02-24 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N217003-001 | ODE-405 | 2029-08-24 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | N217003-001 | PED | 2030-02-24 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | N217003-001 | NP | 2025-08-24 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N217003-001 | PED | 2026-02-24 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N217003-001 | ODE-405 | 2029-08-24 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N217003-001 | PED | 2030-02-24 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N217003-001 | NP | 2025-08-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217003-001 | PED | 2026-02-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217003-001 | ODE-405 | 2029-08-24 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N217003-001 | PED | 2030-02-24 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | NP | 2025-08-24 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | PED | 2026-02-24 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | ODE-405 | 2029-08-24 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N217003-001 | PED | 2030-02-24 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N217003-001 | NP | 2025-08-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217003-001 | PED | 2026-02-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217003-001 | ODE-405 | 2029-08-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N217003-001 | PED | 2030-02-24 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217003-001 | NP | 2025-08-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217003-001 | PED | 2026-02-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217003-001 | ODE-405 | 2029-08-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N217003-001 | PED | 2030-02-24 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N217003-001 | NP | 2025-08-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217003-001 | PED | 2026-02-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217003-001 | ODE-405 | 2029-08-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N217003-001 | PED | 2030-02-24 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217003-001 | NP | 2025-08-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217003-001 | PED | 2026-02-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217003-001 | ODE-405 | 2029-08-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N217003-001 | PED | 2030-02-24 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217003-001 | NP | 2025-08-24 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217003-001 | PED | 2026-02-24 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217003-001 | ODE-405 | 2029-08-24 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N217003-001 | PED | 2030-02-24 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217003-001 | NP | 2025-08-24 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217003-001 | PED | 2026-02-24 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217003-001 | ODE-405 | 2029-08-24 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N217003-001 | PED | 2030-02-24 | 03ed91905a0d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Imbruvica | IBRUTINIB | Pharmacyclics LLC | 0dfd0279-ff17-4ea9-89be-9803c71bab44 | 2025-10-21 | Warnings, Adverse reactions | 217003 NDA217003 57962-007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.